Literature DB >> 7520203

Neurotransmission in the rat amygdala related to fear and anxiety.

M Davis1, D Rainnie, M Cassell.   

Abstract

An impressive amount of evidence from many different laboratories using a variety of experimental techniques indicates that the amygdala plays a crucial role in the acquisition, consolidation and retention or expression of conditioned fear. Electrophysiological data are beginning to detail the transmitters and inter-amygdala connections that transmit information to, within, and out of the amygdala. In general, treatments that increase the excitability of amygdala output neurons in the basolateral nucleus (for example, by decreasing opiate and GABA transmission, and increasing noradrenergic transmission) improve aversive conditioning, whereas treatments that decrease excitability of these neurons (by increasing opiate and GABA transmission, and decreasing NMDA and noradrenergic transmission) retard aversive conditioning as well as producing anxiolytic effects in appropriate animal tests. A better understanding of brain systems that inhibit the amygdala, as well as the role of its very high levels of peptides, might eventually lead to the development of more effective pharmacological strategies for treating clinical anxiety and memory disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520203     DOI: 10.1016/0166-2236(94)90106-6

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  143 in total

1.  Bistable behavior of inhibitory neurons controlling impulse traffic through the amygdala: role of a slowly deinactivating K+ current.

Authors:  S Royer; M Martina; D Pare
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 3.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

4.  An anxiolytic response exerted by beta 3-adrenoreceptor activation: correlation with an enhanced subset of gabaergic synaptic responses.

Authors:  Robert W Greene
Journal:  Neuropsychopharmacology       Date:  2010-08       Impact factor: 7.853

Review 5.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

6.  Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala.

Authors:  Michal Bajo; Samuel G Madamba; Xiaoying Lu; Lisa M Sharkey; Tamas Bartfai; George Robert Siggins
Journal:  Addict Biol       Date:  2011-09-28       Impact factor: 4.280

7.  Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling.

Authors:  Casey E O'Neill; Ryan J Newsom; Jacob Stafford; Talia Scott; Solana Archuleta; Sophia C Levis; Robert L Spencer; Serge Campeau; Ryan K Bachtell
Journal:  Psychoneuroendocrinology       Date:  2016-02-01       Impact factor: 4.905

8.  Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

9.  Effects of acute and chronic inhalation of paint thinner in mice: behavioral and immunohistochemical study.

Authors:  Karim Fifel; Mohamed Bennis; Saâdia Ba-M'hamed
Journal:  Metab Brain Dis       Date:  2013-11-12       Impact factor: 3.584

10.  Amygdala volume in patients receiving chronic corticosteroid therapy.

Authors:  E Sherwood Brown; Dixie J Woolston; Alan B Frol
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.